ESKAYEF (NOW KNOWN AS SMITHKLINE BEECHAM PHARMACEUTICALS (INDIA) LTD. ETC. vs. COMMISSIONER OF INCOME TAX, KARNATAKA-II, BANGALORE
What were the facts?
The appeals before the Supreme Court concerned the assessee, ESKA YEF (now known as SmithKline Beecham Pharmaceuticals (India) Ltd.), and the Revenue. The assessment year in question was 1980-81, and other appeals related to Income Tax References from the Karnataka High Court. The core issues revolved around the admissibility of surtax liability as a deduction and whether expenditure on distributing free samples of prescription drugs to doctors constituted advertisement or sales promotion falling under Section 37(3A) of the Income Tax Act, 1961. The High Court and the Income Tax Appellate Tribunal had previously ruled against the assessee on these points. The Supreme Court was reviewing these decisions.
What did the Supreme Court hold?
The Supreme Court held that surtax liability is not an admissible deduction in computing total income, affirming its previous decision in Smith Kline and French (India) Ltd & Ors. v. Commissioner of Income Tax. Regarding the distribution of physician's samples, the Court held that the target audience for advertising, publicity, or sales promotion of prescription drugs is the doctors who prescribe them. The distribution of samples is intended to make doctors aware of the drugs' availability and efficacy, persuading them to prescribe, which amounts to publicity and sales promotion. The Court found no evidence of feedback collection from doctors to support the assessee's claim. It also clarified that the prohibition under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, does not apply to physician's samples, as it pertains to publication. The Court distinguished the case from Commissioner of Income Tax v. J & J Dechane Laboratories (P) Ltd. by noting the absence of a finding that expenditure was incurred to test drug efficacy. Therefore, expenditure on physician's samples falls within the scope of Section 37(3A) and is subject to its limitations. The appeals were dismissed.
What were the issues?
The Supreme Court had to decide two primary questions of law: 1. Whether the surtax liability is an admissible deduction under Section 37 of the Income Tax Act, 1961. 2. Whether expenditure incurred on the distribution of free samples of prescription drugs to doctors is in the nature of advertisement or publicity or sales promotion, thereby falling within the restrictive provisions of Section 37(3A) of the Act. The assessee contended that the distribution of free samples was for obtaining feedback on drug efficacy and did not constitute advertisement or sales promotion, thus not being subject to Section 37(3A) restrictions. They also referenced Section 3 of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, regarding advertisement prohibitions. The Revenue argued, and the lower authorities agreed, that such distribution was indeed a form of publicity and sales promotion. The Supreme Court relied on its prior judgment in Smith Kline and French (India) Ltd. & Ors. v. Commissioner of Income Tax for the surtax issue.
Which sections of the Income-tax Act were involved?
AI-generated summary — verify with the full judgment below
A ESKA YEF (NOW KNOWN AS SMITHKLINE BEECHAM B PHARMACEUTICALS (INDIA) LTD. ETC. v. COMMISSIONER OF INCOME TAX, KARNA TAKA-11, BANGALORE. JULY 20, 2000 [S.P. BHARUCHA AND MS. RUMA PAL, JJ.] C Income Tax Act, 1961-Section 37-Liability to pay surtax-Whether an admissible deduction in computing total income-Held, not deductible. Section 37(3A)-Expenditure incurred on distribution of free samples of prescription drugs to doctors-Whether in the nature of advertisement or publicity or sales promotion falling within the restrictive provisions of the D section-Held yes. Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954- Section 3-Prohibition of publication of advertisement of a drug-Held, prohibition not applicable to physician's samples. E In these appeals, the following two questions were raised: F I. Whether the surtax liability is an admissible deduction under section 37 of the Income Tax Act, 1961?
Whether ex.penditure incurred on distribution of free samples of prescription drugs to doctors is in nature of advertisement falling within the restrictive provisions of section 37(3A) of the Act? Appellant-assessee contended that the expenditur
The order continues below.
Read the full judgment
A free account opens 10 full judgments a month. Re-reading one you have already opened does not count again.
The summary, the parties, the sections and the citations above are open to everyone and always will be. Only the text of the order and the PDF are metered.
More judgments on Section 37
- Mohammed Javed Bhati, Sikar vs Income Tax Officer, Ward 1, SikarITA 994/JPR/2025[2018-19]Status: Disposed21 Oct 2026AY 2018-19
- Deputy Commissioner of Income Tax, Circle… vs Sun Pharma Advanced Research Company…ITA 933/AHD/2025[2013-14]Status: Disposed15 Oct 2026AY 2013-14
- Deputy Commissioner of Income Tax, Circle… vs Sun Pharma Advanced Research Company…ITA 932/AHD/2025[2015-16]Status: Disposed15 Oct 2026AY 2015-16
- Deputy Commissioner of Income Tax, Circle… vs Sun Pharma Advanced Research Company…ITA 931/AHD/2025[2014-15]Status: Disposed15 Oct 2026AY 2014-15
- Sun Pharma Advanced Research Company… vs The ACIT, Circle-2(1)(1), VadodaraITA 768/AHD/2025[2015-16]Status: Disposed15 Oct 2026AY 2015-16
Recent GST High Court judgments
Search GST case law →- M/S Bidasaria Fenster Solutions vs. The State Of BiharPatna · 13 Oct 2026
- Amit Agency vs. Commissioner, CGST And CxPatna · 13 Oct 2026
- M/S National Book Distributors vs. Assistant Commissioner State TaxUttarakhand · 13 Oct 2026
- M/S D H Enterprise vs. The State Of Assam And 2 Ors.Gauhati · 12 Oct 2026
- Commissioner Of Service Tax-Ii Presently Known As Commissioner Of CGST And Cx Kolkata South vs. M/S Alfa Aluminium Private LimitedCalcutta · 12 Oct 2026